Enterprise Financial Services Corp Abbott Laboratories Transaction History

Enterprise Financial Services Corp

$177 Million
Q4 2024

A detailed history of Enterprise Financial Services Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Enterprise Financial Services Corp holds 8,975 shares of ABT stock, worth $1.13 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

8,975

Previous 9,059 0.93%

Holding current value

$1.13 Million

Previous $1.03 Million 1.65%

% of portfolio

0.57%

Previous 0.61%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$111.93 - $119.39 $9,402 - $10,028	-84 Reduced 0.93%	8,975 $1.02 Million
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $60,542 - $71,468	-605 Reduced 6.26%	9,059 $1.03 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $53,286 - $59,480	-529 Reduced 5.19%	9,664 $1 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $40,522 - $44,755	-370 Reduced 3.5%	10,193 $1.16 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $3,066 - $3,753	-34 Reduced 0.32%	10,563 $1.16 Million
Q3 2023 Oct 31, 2023	SELL	$95.53 - $114.62 $276,845 - $332,168	-2,898 Reduced 21.47%	10,597 $1.03 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $358,474 - $399,415	3,557 Added 35.79%	13,495 $1.47 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $13,754 - $16,189	-142 Reduced 1.41%	9,938 $1.01 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $6,559 - $7,694	69 Added 0.69%	10,080 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $15,384 - $17,812	-159 Reduced 1.56%	10,011 $969,000
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $40,725 - $49,224	399 Added 4.08%	10,170 $1.11 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $4,674 - $5,700	-41 Reduced 0.42%	9,771 $1.16 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $112,179 - $137,357	-971 Reduced 9.0%	9,812 $1.38 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $254,318 - $281,350	2,180 Added 25.34%	10,783 $1.27 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $8,992 - $10,585	-85 Reduced 0.98%	8,603 $997,000
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $10,884 - $12,822	100 Added 1.16%	8,688 $1.04 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $69,195 - $75,402	-659 Reduced 7.13%	8,588 $941,000
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $46,186 - $56,090	504 Added 5.76%	9,247 $1.01 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $304,672 - $389,942	-3,979 Reduced 31.28%	8,743 $799,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $44,476 - $65,036	-708 Reduced 5.27%	12,722 $1 Million
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $83,927 - $93,430	-1,069 Reduced 7.37%	13,430 $1.17 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $37,891 - $41,086	-463 Reduced 3.09%	14,499 $1.21 Million
Q2 2019 Jul 30, 2019	SELL	$72.88 - $85.0 $62,020 - $72,335	-851 Reduced 5.38%	14,962 $1.26 Million
Q1 2019 Apr 26, 2019	BUY	$66.22 - $80.06 $75,689 - $91,508	1,143 Added 7.79%	15,813 $1.27 Million
Q4 2018 Jan 25, 2019	SELL	$65.56 - $74.27 $69,165 - $78,354	-1,055 Reduced 6.71%	14,670 $1.06 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $72,972 - $88,032	-1,200 Reduced 7.09%	15,725 $1.15 Million
Q2 2018 Jul 27, 2018	SELL	$57.57 - $63.54 $18,595 - $20,523	-323 Reduced 1.87%	16,925 $1.03 Million
Q1 2018 Apr 27, 2018	SELL	$56.27 - $63.62 $57,057 - $64,510	-1,014 Reduced 5.55%	17,248 $1.03 Million
Q4 2017 Jan 26, 2018	BUY	$53.68 - $57.47 $5,690 - $6,091	106 Added 0.58%	18,262 $1.04 Million
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $872,577 - $973,887	18,156	18,156 $969,000

Others Institutions Holding ABT

# of Institutions

3,377

Shares Held

1.33B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $220B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.

Account

Enterprise Financial Services Corp Abbott Laboratories Transaction History